Iomab-ACT: A Pilot Study of 131-I Apamistamab Followed by CD19-Targeted CAR T-Cell Therapy for Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia or Diffuse Large B-Cell Lymphoma
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Massachusetts General Hospital
The First Affiliated Hospital of Soochow University
St. Jude Children's Research Hospital
Sun Yat-sen University
Sun Yat-sen University